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2ABSTRACT
The central role for PrP in the pathogenesis of the transmissible spongiform encephalopathies 
(TSEs) is illustrated by the resistance of Prnp0/0 mice to disease and by the inverse association of 
Prnp gene dosage with incubation period. Understanding the role of PrPC in TSEs necessitates 
knowledge of expression levels of the Prnp gene during the development of disease. SSBP/1 
scrapie shows a defined pattern of disease progression and here we show that Prnp and shadow of 
PrP (Sprn) are differentially expressed in different brain areas and lymphoid tissues. Counter-
intuitively we found that there is no positive correlation between expression of Prnp or Sprn and 
patterns of disease progression. Prnp and Sprn expression levels are both influenced by Prnp 
genotype; although the scrapie-sensitive VRQ/VRQ sheep did not express the highest level of 
either. In addition, infection with SSBP/1 scrapie seems to have little effect on either PrP or 
Shadoo expression levels. 
Keywords: Prion; scrapie; shadoo; PrP genetics; mRNA expression.
31.  Introduction
The central role for cellular prion protein, PrPC in the pathogenesis of the transmissible 
spongiform encephalopathies (TSEs) is illustrated by the resistance of Prnpnull mice (which 
express no PrP protein) to disease and by the inverse association of the normal cellular PrPC
expression levels with incubation period in transgenic mice [1;2]. Furthermore in sheep scrapie, 
susceptibility and resistance to infection is largely controlled by polymorphisms of the PrP gene 
(Prnp) at codons 136 (valine, V, or alanine, A), 154 (arginine, R, or histidine H) and 171 
(arginine, R or glutamine, Q,).  Following experimental challenge with SSBP/1 scrapie by 
peripheral routes, VRQ/VRQ sheep have considerably shorter incubation period than VRQ/ARR 
sheep and ARR homozygotes are resistant. Furthermore, heterozygous animals of different breeds 
have variable incubation periods relative to homozygous genotypes, implying that factors other 
than PrP are influencing disease [3].
The prion gene (Prn) complex consists of two homologous genes [4], Prnp encodes the 
ubiquitously-expressed PrP and Prnd encodes doppel (Dpl), which is truncated at the amino 
terminus, is expressed almost exclusively in testes and heart [5] and seems to play little role in 
TSE pathology. However, in Prnpnull mice Dpl is ectopically-expressed in the central nervous 
system (CNS) and, like amino-terminally truncated PrP (ΔPrP), causes neurodegeneration and
ataxia [4]. A second homologue called shadow of prion protein (Shadoo or Sho), encoded by the 
Prnp-unlinked gene Sprn [6], is expressed in the CNS and, like full length PrP, protects the brain 
from the neurotoxic effects of Dpl and ΔPrP [7]. Consequently, Sho might be one of the factors, 
other than PrP, that influences disease progression.
Scrapie strains in mice are differentiated by their different and reproducible incubation times 
in defined mouse strains. In addition scrapie isolates in sheep exhibit characteristic patterns of 
deposition of disease-associated PrPSc in specific regions of the CNS and in lymphoreticular 
system (LRS) {Gonzalez, 2002 18162 /id}. SSBP/1 scrapie is a well characterised sheep scrapie 
strain and shows a sequential progression of PrPSc deposition [8], from lymph nodes, tonsils and 
4spleen in the LRS, to obex (medulla), thalamus and then cerebellum and frontal cortex in the 
CNS. 
In this study we used real-time quantitative RT-PCR (qRT-PCR) to quantify PrP and Sho 
transcripts in peripheral lymphoid tissues and the brains of sheep experimentally infected with 
SSBP/1 scrapie. In this way we tested the hypotheses that; (1) differential expression of PrP and 
Sho explain the patterns of SSBP/1 scrapie disease progression, (2) expression levels of PrP and 
Sho are related to differential susceptibility to scrapie pathology and disease of different Prnp 
genotypes and (3) PrP and Sho expression levels change in relation to the development of disease.
Materials and Methods
Experimental animals, scrapie infections and tissue collection. New Zealand-derived 
Cheviot sheep of three different Prnp genotypes (VRQ/VRQ, VRQ/ARR and ARR/ARR) from 
the DEFRA breeding flock were placed in groups of five animals (three infected animals and two 
mock-infected controls) per time point. All were inoculated by subcutaneous injection with 
SSBP/1 scrapie or normal brain homogenate in the drainage area of the prescapular lymph nodes
(PSLNs) [9]. Animal experiments were performed under an Animals (Scientific Procedures) Act 
1986 Project Licence. Animals were killed by exsanguination under terminal anaesthesia and 
tissues were removed immediately post mortem. Dissected tissues were stored in RNAlater 
(Ambion, Huntingdon, UK) at –80˚C. Spleens were dissected and disrupted by passing through a 
fine steel sieve in ice-cold PBS containing 4 mM EDTA and then filtered through muslin. 
Follicular dendritic cells (FDC) were enriched using an Optiprep gradient (Nycomed Amersham, 
Little Chalfont, UK) with the cells at the 1.068 g/ml – PBS interface being collected after 
centrifugation at 600×g for 25 min at 20 °C. Cells were washed in PBS/EDTA and pelleted at 
300×g, before they were lysed using 1 ml of RNAwiz (Ambion) per 107 cells. 
5RNA extraction and cDNA synthesis. Total RNA from brain tissue was prepared using 
RNeasy Lipid Tissue Mini Kit (Qiagen, Crawley, UK) and from lymphoid tissue using
Ribopure Kit (Ambion). RNA was digested with DNase I, assessed using a RNA 6000 Nano 
LabChip on the Agilent 2100 bioanalyzer and quantified using a NanoDrop ND-1000 
spectrophotometer. First strand cDNA synthesis used 0.5 μg of total RNA with 50 μM 
oligo(dT)20, 40 U RNaseOUT, 200 U Superscript ™ III reverse transcriptase, 5× RT buffer, 25 
mM MgCl2 and 0.1 M DTT (Invitrogen, Paisley, UK). Genomic DNA contamination was 
assessed using a no reverse transcriptase control. For each sample three identical RT reactions 
were performed and prepared at the same time. 
Construction of plasmid standards. Primer sequences, amplicon sizes and optimized 
conditions are listed in Supplementary Table 1. Amplicons were cloned using pGEM-T Easy kit 
(Promega, Southampton, UK), assessed by gel electrophoresis and sequenced. Purified plasmid 
DNA was linearized; plasmid concentration determined using a NanoDrop ND-1000 
spectrophotometer and serial dilutions generated using a CAS-1200™ (Corbett Robotics, Sydney, 
Australia). Standard curves were prepared for all genes; 7-fold serial dilutions were made from 1 
ng/µl. Copy numbers were calculated by; the molecular weight of vector plus insert (M) = size of 
plasmid and insert size bp × 660 g/mol per bp. Number of molecules per ng = [(1×10-9)/(M 
g/mol)] × (6.023×1023 molecules/mol). The Prnp primers amplified bp 783 – 914 encoding amino 
acids 207 – 251 (Genbank accession no. NM_001009481); the Sprn primers amplified bp 2033 –
2177 (Genbank accession no. DQ870545) located in the 5’ untranslated region (33 bp) and the 5’ 
of the coding region (111 bp). These primers were not associated with any known polymorphisms.
Quantitative real-time RT-PCR. qRT-PCR was performed using the Rotor-
Gene™ 3000 (Corbett); all qRT-PCR reactions were prepared using a CAS-1200™. All reactions 
were performed in 10 μl final volume containing 5 μl cDNA at optimal dilution (1:20), 0.375 U 
FastStart Taq DNA Polymerase, 10× PCR reaction buffer, MgCl2 at optimal concentration, 200 
6µM of each dNTP, 0.35 μl SYBR Green I (1/1000 in DMSO) and 0.5 μl of each primer at optimal
concentration. The amplification profile used was the same for each gene except for annealing 
temperature (Supplementary Table 1): 5 min at 94ºC, 40 cycles of 15 s at 94ºC, 15 s at gene 
specific annealing Tm and 15 s at 72ºC, followed by a dissociation curve analysis program. Each 
sample was assayed in triplicate in the same run and each included a no-template control and a 
plasmid DNA standard curve for each gene. The dynamic range of the standard curve spanned 
five orders of magnitude and was used to derive copy number of the target sequence in unknown 
samples. The data were analyzed using Rotor-Gene 3000 Software v 6.1.81 (Corbett). 
Amplified products were assessed by melt curve analysis; linearity and efficiency of 
qPCR amplification was determined for each primer pair using a standard curve generated by a 
dilution series of a pool of sample cDNAs for each tissue. Several genes were evaluated for 
suitability as endogenous reference genes for each of the different tissues using GeNorm v3.4 and 
NormFinder v 0.953 (Supplementary Table 1).
Normalized copy numbers were obtained by using the normalization factor determined by 
GeNorm for each tissue assayed based on the expression of multiple endogenous reference genes 
previously determined for each individual tissue (Supplementary Table 1). The expression levels 
were normalized by dividing the copy number derived from the standard curve by the calculated 
normalization factor for each individual sample. The geometric mean of the normalized 
expression levels for the three reverse transcriptions performed for each sample was used in 
analysis of expression levels of each gene.
For Prnp, the detection limit was 3 molecules but with the highest test linearity in the 
quantification range of 35.9 - 2.96×107 plasmid DNA molecules. The detection limit was 2 
molecules for Sprn, with a quantification range of 36 - 4.21×106 molecules. qRT-PCR efficiencies 
and R2 values were 100% for Prnp (R2= 0.999) and 98% for Sprn (R2= 0.998). 
Statistical analysis. Datasets were tested for normal (Gaussian) distribution using the 
D'Agostino & Pearson omnibus K2 normality test. As the vast majority passed, normal 
7distribution was assumed for all and comparisons were completed using one-way analysis of 
variance (ANOVA) followed by Student’s t-test (P < 0.05 for differences between groups was 
consider significant).
Results
Tissue specific expression of Prnp and Sprn transcripts
Expression levels of Prnp and Sprn in different tissues were examined in sheep of the 
VRQ/VRQ genotype (Table 1). This was related to the known pattern of disease progression with 
SSBP/1, where PrPSc deposition is first seen in the draining PSLNs, then spleen; and in the CNS, 
first obex and thalamus, then cerebellum and frontal cortex [9]. These data show that within the 
brain there is a hierarchy of expression of both Prnp and Sprn and that the pattern is similar for 
both Prnp and Sprn. In descending order this hierarchy is: frontal cortex>cerebellum>obex and 
thalamus. Table 1 also shows that Prnp is expressed at a level 100 to 1000 fold greater than Sprn.
In PSLNs, Prnp levels are about 20 fold less that in obex but Sprn levels are approximately 
equivalent. In contrast, within processed spleen Prnp levels are 3 - 4 fold greater than PSLN but 
Sprn transcripts were below the level of accurate quantification.
Effect of Prnp genotype on Prnp and Sprn transcripts 
Differences in levels of Prnp transcripts in sheep with distinct Prnp genotypes were 
assessed using obex, spleen and prescapular lymph node; spleen was replaced by frontal cortex for 
Sprn measurement because of the lack of detectable Sprn in spleen. Comparison of Prnp transcript 
levels in the three genotypes is shown in Fig. 1 and shows that the highest level of expression is in 
VRQ/ARR sheep. Within obex the levels of Prnp in VRQ/ARR sheep were 1.9 × 106 copies per 1 
8μg of RNA, significantly greater (P ≤ 0.05) than both the VRQ/VRQ and ARR/ARR groups. In 
spleen the Prnp levels in the heterozygotes (3.7 × 106) were significantly greater (P ≤ 0.05) than 
VRQ/VRQ sheep and in lymph node they were significantly higher (P ≤ 0.05) than the ARR/ARR 
animals. Fig. 2 shows equivalent data for Sprn, and shows no significant difference in the 
expression level in frontal cortex between genotypes, but the Sprn level in lymph nodes was 
significantly higher in ARR/ARR animals than in VRQ/VRQ. In obex, Sprn transcripts in 
VRQ/ARR and ARR/ARR sheep were too low to be accurately quantified and therefore valid 
comparisons could not be made.
Effect of scrapie infection on Prnp and Sprn transcripts
The effect of SSBP/1 scrapie infection on Prnp and Sprn transcript levels was assessed in 
different tissues on days 25, 75 and 125 post-infection in VRQ/VRQ sheep and days 25, 75, 150 
and 230 in VRQ/ARR and ARR/ARR animals. Transcript levels in mock-infected animals (C)
were also measured, and data for Prnp in obex and lymph node are shown in Fig. 3. Analysis was 
performed comparing every time point with all others and also comparing early infection (days 25 
and 75) with late infection (day 125, 150 and 230). These analyses showed that infection with 
SSBP/1 has no significant effect (P>0.05) on expression of either Prnp or Sprn in any tissue 
examined (frontal cortex, cerebellum, obex, thalamus, spleen and PSLN).
Discussion
This study quantified Prnp and Sprn transcripts, in different areas of the CNS and LRS in 
sheep of defined Prnp genotypes and at times after SSBP/1 scrapie infection. The rationale for 
these studies was to examine the relationship between differential Prnp and Sprn expression and
(1) the pattern of progression of SSBP/1 scrapie pathology; (2) differential susceptibility of 
9different Prnp genotypes to SSBP/1 disease and (3) time after SSBP/1 scrapie infection. In this 
study we measured transcripts and assume a direct, quantitative relationship between PrP/Sho 
protein and mRNA levels. At least two Prnp transcripts have been described resulting from 
alternative polyadenylation sites [10], which may have different stability rates and tissue 
distributions. However, the primers used were within the coding region and therefore amplified all 
possible variants.
Our data are consistent with the reports of Diaz-San Segundo [11] and Tichopad [12], and 
show a hierarchy of expression level of Prnp in the CNS; with thalamus and obex expressing the 
lowest level, then cerebellum with the highest level in frontal cortex. However, this contradicts
Han [13] who report that obex expresses the highest level of Prnp. We also show a hierarchy in 
the LRS with Prnp transcript levels in spleen being approximately threefold those of prescapular 
lymph node. The only previous data on sheep Sprn expression used non-quantitative methods and 
showed that it is expressed within the CNS [14]. Here we show that Sprn is expressed at a level at 
least two orders of magnitude below Prnp but has a hierarchy of expression in the CNS regions 
identical to Prnp. However, in the LRS the hierarchy is reversed, the spleen expresses very little 
Sprn.
Despite the fact that incubation period of scrapie disease in transgenic mice is inversely 
related to transgene copy number [2], it is clear from these data that there is no positive 
relationship between quantitative levels of Prnp and Sprn expression and scrapie pathology. 
Within the CNS the regions showing PrPSc accumulation earliest are obex and thalamus, which 
express the lowest level of Prnp/Sprn of the four regions examined. Frontal cortex consistently 
expresses the highest levels of Prnp but shows no signs of pathology until terminal stages of 
disease [9]. These data show that tissues with the highest levels of Prnp and Sprn expression are 
the last areas to show PrpSc deposition. 
The progression of pathology in the LRS might be explained by anatomy rather than 
quantitative expression of either Prnp or Sprn. Sheep were infected by SSBP/1 inoculation in the 
drainage area of the PSLNs, and it was these nodes that showed first signs of PrPSc accumulation. 
In naturally-infected sheep, lymph nodes and spleen seem to show pathology at approximately the 
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same time [15], with infection being disseminated within lymph and blood plasma [16;17] or 
associated with migrating cells [18]. Despite the fact that CNS is likely to become infected from 
the periphery via spinal nerves [19], anatomy is unlikely to be the simple explanation for the 
pattern of progression within the brain. Obex (medulla) is not apparently affected in some strains 
of ovine and murine scrapie [20;21] and non-stereotaxic intracranial inoculation of mice with 
different strains of scrapie results in strain-consistent pathological profiles [22].
Flow cytometry has previously shown that Prnp genotype influences the quantitative 
expression of PrP by different blood components [23], with the highest level of PrPC being in 
scrapie-susceptible VRQ/VRQ sheep, the lowest in scrapie-resistant ARR/ARR sheep. These 
reports imply that susceptibility of different genotypes is positively linked to quantitative PrPC
expression; but our data and those of Garcia-Crespo [24] show that for obex and the LRS, Prnp 
levels are significantly highest in the heterozygote sheep with intermediate susceptibility. One 
explanation for these results could be that quantitative expression of PrPC is controlled at the 
translation level and not by gene transcription. Recently, Morel [25] illustrated that the principal 
mechanism of scrapie resistance in Prnp allelic variants is through different efficiencies of 
conversion of PrPC to PrPSc. Using MALDI-TOF of VRQ/ARQ sheep they showed that both 
variants are represented equally in PrPC but that the VRQ variant predominates in PrPSc. Our data 
also show that Sprn expression levels in PSLN but not other tissues are highest in resistant 
ARR/ARR sheep. This implies the existence of a common mechanism controlling these 
genetically unlinked, but homologous genes. 
Our results show that expression of Prnp or Sprn in different areas of the brain,
prescapular lymph node or spleen was unaffected by SSBP/1 scrapie at any stage of infection. 
This contrasts with a previous report that indicates that scrapie infection causes an increase in 
expression level of PrP in ileal Peyer’s patches follicles, but not whole ileal Peyer’s patches ten 
months after oral infection [26]. This report also demonstrates that in infected ileal Peyer’s 
patches there are PrPSc high and PrPSc low follicles, but that they express identical levels of Prnp. 
As with data in this report this indicates the lack of direct relationship between quantitative levels 
of PrP expression and scrapie pathology.
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Figure Legends
Fig.1. Expression levels of Prnp transcripts in the obex, spleen and prescapular lymph node of 
sheep with defined Prnp genotype. Data points are mean replicates from individual sheep, ± 
standard deviation and group mean; n ≥ 9, but points not plotted if they fall outside the linear 
range of the calibration curve.
Fig.2. Expression levels of Sprn transcripts in the frontal cortex, obex and prescapular lymph 
node of sheep with defined Prnp genotype. Data points are mean replicates from individual sheep, 
± standard deviation and group mean; n ≥ 9, but points not plotted if they fall outside the linear 
range of the calibration curve.
Fig.3. Expression levels of Prnp transcripts in the obex and prescapular lymph node of sheep 
with defined Prnp genotype at times after SSBP/1 scrapie infection and in mock-infected sheep 
(C). Data are group means ± standard deviation.  
Table 1
Expression levels of Prnp and Sprn transcripts in the brain and 
peripheral lymphoid tissue of VRQ/VRQ sheep.
Tissue Copy  number per 1 μg  RNA ± SD
Frontal Cortex Prnp 3.4 x 10
6 ± 5.1 x 105
Sprn 1.8 x 104 ± 7.9 x 103
Cerebellum Prnp 2.7 x 106 ± 6.1 x 105
Sprn 7.4 x 103 ± 1.6 x 103
Obex Prnp 1.5 x 106 ± 4.8 x 105
Sprn 2.5 x 103 ± 371
Thalamus Prnp 1.5 x 106 ± 3.7 x 105
Sprn 3.1 x 103 ± 633
Spleen Prnp 2.6 x 105 ± 8.3 x 104
Sprn 307 ± 478 *
Lymph Node Prnp 7.7 x 104 ± 1.4 x 104
Sprn 3.0 x 103 ± 603
* below level of accurate quantification
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